The threshold for new drugs to enter the hospital is high! Non-medical insurance, medium-sized drugs are limited!

Medical Network August 3, July 27, Sichuan University Huaxi Hospital issued a new round of new drug data declaration announcement, causing industry concern.
the first point of the new drug declaration rules of Huaxi Hospital is to be in the new version of the National Health Insurance Directory, and the category of certain requirements, must belong to the "digestion and metabolism of drugs, skin disease drugs, nervous system drugs, anti-tumor drugs and immunomodulators."
, Traditional Chinese medicine has again been restricted to admission to hospital.
non-medical insurance new drug "difficult to enter the hospital" it is understood that, according to the national health insurance bureau arrangements, the new version of the National Health Insurance Directory on January 1, 2020 officially implemented.
comes after Huaxi Hospital issued a round of new drug introduction announcements on January 3.
comparing the two chemical drug categories, both mentioned the introduction of anti-tumor drugs and immunomodulators, which also shows that the hospital's need for new drugs against cancer drugs is more urgent.
indeed, from the first time this year finally introduced 66 varieties, anti-tumor drugs occupy a larger proportion, is sunny Anrotini, Hengrui's methicillate apatinib, Cinda's Cindilli single anti-injection injectionare are among them.
note is that according to Huaxi requirements, only new drugs can be admitted to the hospital, not new drugs of health insurance can not be admitted to the hospital for sale.
to PD-1 as an example, the domestic has been listed 6 varieties, only Cinda through price negotiations to enter health insurance, by virtue of "health insurance status", Cinda's PD-1 has successfully entered the Huaxi hospital sales, although the remaining 5 varieties have been in the provinces have been rapidly linked to the network, but facing the dilemma of not being able to enter the hospital.
in a pharmaceutical company general manager said: "Now on the whole, the speed of new drugs into the hospital is not fast, because the new drug into the hospital is more sensitive, on the one hand, the new drug into the hospital procedures, the process is complex."
on the other hand, now each hospital varieties are many, under various policies, are in a way to kick varieties, so in a state of progress.
this environment, non-medical lying is less likely to be in hospital, unless it is a special drug, including clinically urgently needed drugs, orphan drugs, and less replaceable drugs.
" interview reporters also learned that the current non-health insurance new drugs also have a variety of sales methods, such as yard side shop, yard shop, DTP and so on.
, however, even with some sales channels, the inability to go to hospitals has limited sales growth.
in the words of the industry, not being able to get into a hospital is equivalent to not being able to enter mainstream channels.
limits on traditional Chinese medicine is of concern, in 2015, Huaxi Hospital because of the new drug declaration refused the national drug quasi-number with "Z" beginning with the traditional Chinese medicine (with the exception of single-component content of more than 85% of the total extract of injections) caused a discussion.
and in the latest introduction of new drugs, Huaxi also directly clear, can introduce the medical insurance catalog of traditional Chinese medicine, but only the recipient of the national drug quasi-number Z belongs to the first class of new drugs, or belong to the national negotiation varieties, or access to the provincial scientific and technological progress first prize and above the varieties of scientific and technological awards.
different from the situation of the new version of the national health insurance catalog to significantly add the number of traditional Chinese medicine, the new version of the 2019 health insurance catalog adjustment, the regular access part added a total of 148 varieties, of which 47 Western medicine, 101 Chinese medicine, the new number of Chinese medicine is twice the number of Western medicine.
and in accordance with the requirements of Huaxi Hospital, the number of eligible Chinese medicine is not much.
the general manager of the aforementioned pharmaceutical company analysis said: "These requirements are basically the same as the last time refused to allow Chinese medicine into the hospital meaning?" Because class 1 new drug was approved less, the country negotiating varieties of traditional Chinese medicine is also very limited, can get the first prize of provincial scientific and technological progress and above scientific and technological awards of traditional Chinese medicine is also very few, so look down, is equal to not let into the hospital.
" for why the restrictions on traditional Chinese medicine into the hospital, there are business people told reporters: "Because the hospital inside the chinese medicine species a lot, now many three-a hospital are kicking the variety of discharge, generally will be the first target to Chinese medicine, so the difficulty of Chinese medicine into the hospital is very large, even if the entrance is also a small number."
but not admitted to the hospital does not mean that the hospital does not use traditional Chinese medicine, and the practice of each hospital is not the same.
on the whole, in grade hospitals, especially in the hospital, Chinese traditional medicine is very difficult to enter.
" admission to the hospital increment is guaranteed then, new drugs into the hospital sales, especially into such as Huaxi "carrier-class" hospitals, the increase is considerable? What preparations can companies make? According to the National Health and Health Commission Office issued "on the 2018 national three-level public hospital performance appraisal of the national monitoring and analysis of the relevant situation" shows that the first round of the performance of the third-level public hospitals "national examination", Sichuan University Huaxi Hospital in the country's 2398 participating hospitals in the overall second place, the assessment rating of A.
at present, Huaxi Hospital's maximum daily emergency capacity of more than 20,000 people.
2019, there were 5.7385 million door and emergency visits.
the aforementioned enterprise people believe: "If the variety can enter Huaxi, to this scale of emergency measures, the variety does not have to worry about sales."
" the general manager of the aforementioned pharmaceutical company said: "a variety can enter the hospital, whether it is the hospital, or industrial enterprises, distribution enterprises are doing a lot of pre-work, there are these mats, generally after going in, sales will certainly be better protection."
for enterprises, if it is non-medical insurance varieties, unless the variety has a special effect, with full certainty, otherwise are doing useless work.
at present, enterprises still want to first to the variety into health insurance, regular additions, negotiations and other ways can be, into the medical insurance and then to carry out the work of the hospital.
"